홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

1,1'-(9,9-Dimethyl-9H-xanthene-4,5-diyl)bis(1,1-diphenylphosphine) → (S)-1-((2,2-dimethyl-1,3-dioxolan-4-yl)methyl)-N-(3'-fluoro-6'-methyl-2,2'-bipyridin-4-yl)-1H-pyrazolo[4,3-b]pyridin-7-amine

HRID 1522608
인쇄

반응식

HRID 1522608 반응식
[CH3:1][C:2]1([CH3:18])[O:6][C@@H:5]([CH2:7][N:8]2[CH:17]=[C:11]3[N:12]=[CH:13][CH:14]=[C:15](I)[C:10]3=[N:9]2)[CH2:4][O:3]1.CC1(C)C2C=CC=C(P(C3C=CC=CC=3)C3C=CC=CC=3)C=2OC2C1=CC=CC=2P(C1C=CC=CC=1)C1C=CC=CC=1.[F:61][C:62]1[C:63]([C:69]2[CH:74]=[C:73]([NH2:75])[CH:72]=[CH:71][N:70]=2)=[N:64][C:65]([CH3:68])=[CH:66][CH:67]=1.CC([O-])(C)C.[Na+]>O1CCOCC1.C1C=CC(/C=C/C(/C=C/C2C=CC=CC=2)=O)=CC=1.C1C=CC(/C=C/C(/C=C/C2C=CC=CC=2)=O)=CC=1.C1C=CC(/C=C/C(/C=C/C2C=CC=CC=2)=O)=CC=1.[Pd].[Pd]>[CH3:18][C:2]1([CH3:1])[O:6][C@@H:5]([CH2:7][N:8]2[C:17]3[C:11](=[N:12][CH:13]=[CH:14][C:15]=3[NH:75][C:73]3[CH:72]=[CH:71][N:70]=[C:69]([C:63]4[C:62]([F:61])=[CH:67][CH:66]=[C:65]([CH3:68])[N:64]=4)[CH:74]=3)[CH:10]=[N:9]2)[CH2:4][O:3]1
참가 물질반응 조건실험 절차후처리출처 및 근거반응 노트

참가 물질

7

반응물 4

HCID 6360441,1'-(9,9-Dimethyl-9H-xanthene-4,5-diyl)bis(1,1-diphenylphosphine)HCID 23676156Sodium t-butoxideHCID 674696053'-Fluoro-6'-methyl-2,2'-bipyridin-4-amineHCID 67469660(S)-2-((2,2-dimethyl-1,3-dioxolan-4-yl)methyl)-7-iodo-2H-pyrazolo[4,3-b]pyridine

생성물 1

HCID 67470506
(S)-1-((2,2-dimethyl-1,3-dioxolan-4-yl)methyl)-N-(3'-fluoro-6'-methyl-2,2'-bipyridin-4-yl)-1H-pyrazolo[4,3-b]pyridin-7-amine

시약·촉매·용매 2

HCID 9811564Bis(dibenzylideneacetone)palladium촉매HCID 312751,4-Dioxane용매

반응 조건

온도
120 °C

실험 절차

(S)-2-((2,2-Dimethyl-1,3-dioxolan-4-yl)methyl)-7-iodo-2H-pyrazolo[4,3-b]pyridine (51 mg, 0.142 mmol), Tris(dibenzylideneacetone)dipalladium(0) (3.25 mg, 3.55 μmol), (9,9-dimethyl-9H-xanthene-4,5-diyl)bis(diphenylphosphine) (20.54 mg, 0.035 mmol), 3′-fluoro-6′-methyl-2,2′-bipyridin-4-amine (28.9 mg, 0.142 mmol) and sodium 2-methylpropan-2-olate (40.9 mg, 0.426 mmol) were combined in dioxane (5 mL). The mixture was heated at 120° C. for 2 hours, then cooled and purified by preparative HPLC using a Phenomenex Gemini Prep 5 μm C18, 75×30 mm column eluting with a gradient of 5-40% acetonitrile (containing 0.035% TFA) in water (containing 0.05% TFA) to give (S)-1-((2,2-dimethyl-1,3-dioxolan-4-yl)methyl)-N-(3′-fluoro-6′-methyl-2,2′-bipyridin-4-yl)-1H-pyrazolo[4,3-b]pyridin-7-amine which was combined with methanol (5 mL) and 1N HCl (2 mL) and stirred at room temperature for 30 minutes before evaporation to afford the title compound (12.5 mg, 22.32% yield) as a HCl salt. 1H NMR (400 MHz, METHANOL-d4) δ ppm 2.57 (s, 3H) 3.41 (m, 1H) 3.49 (m, 1H) 3.97-4.10 (m, 1H) 4.51 (m, 1H) 4.69 (m, 1H) 7.51 (dd, J=8.59, 3.54 Hz, 1H) 7.64 (d, J=6.32 Hz, 1H) 7.71 (dd, J=11.24, 8.72 Hz, 1H) 8.01 (d, J=5.05 Hz, 1H) 8.53 (s, 1H) 8.63 (d, J=6.32 Hz, 1H) 8.66-8.71 (m, 2H). MP 182-184° C. MS [M+H] found 395.3.

후처리

  1. temperaturecooled
  2. custompurified by preparative HPLC
  3. washeluting with a gradient of 5-40% acetonitrile (containing 0.035% TFA) in water (containing 0.05% TFA)

출처 및 근거

ORD 기록
ord-3e5b2cad35ca45ebb96eaa779975d5b8
출처 데이터셋
uspto-grants-2015_07
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US09073918B2

반응 노트

이 페이지에서참가 물질반응 조건실험 절차후처리출처 및 근거반응 노트